Medigard Ltd. | Income Statement
Fiscal year is July-June. All values AUD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
64.30
15.60
Cost of Goods Sold (COGS) incl. D&A
62.00
50.10
19.50
19.00
18.60
15.60
Gross Income
62.00
50.10
19.50
19.00
45.70
15.60
SG&A Expense
173.50
271.70
204.30
208.10
270.20
585.10
EBIT
271.30
321.80
250.40
227.10
224.50
600.70
Unusual Expense
57.60
-
317.40
291.30
126.80
30.60
Non Operating Income/Expense
-
-
-
43.30
-
35.50
Interest Expense
-
6.00
19.70
27.40
26.00
20
Pretax Income
322.20
326.70
585.30
81.00
122.70
614.60
Consolidated Net Income
322.20
326.70
585.30
81.00
122.70
614.60
Net Income
322.20
326.70
585.30
81.00
122.70
614.60
Net Income After Extraordinaries
322.20
326.70
585.30
81.00
122.70
614.60
Net Income Available to Common
322.20
326.70
585.30
81.00
122.70
614.60
EPS (Basic)
0.00
0.00
0.01
0.00
0.00
0.01
Basic Shares Outstanding
91,007.50
91,007.50
91,007.50
91,007.50
91,007.50
106,235.40
EPS (Diluted)
0.00
0.00
0.01
0.00
0.00
0.01
Diluted Shares Outstanding
91,007.50
91,007.50
91,007.50
91,007.50
91,007.50
106,235.40
EBITDA
233.30
295.10
230.90
208.10
206.00
585.10
Other Operating Expense
35.80
-
26.60
-
-
-
Non-Operating Interest Income
6.60
1.10
2.20
1.00
1.00
1.20
About Medigard
View Profile
